Strides Pharma Science Ltd 2025 Annual Report with Sustainability Disclosures
Company: Strides Pharma Science Ltd
Sector: Manufacturing
Country: India
Year: 2025
Type: Annual Report with Sustainability Disclosures
Pages: 436
The report presents FY 2024-25 as a year of strategic reset, with consolidated revenue of ₹45,653 Mn and EBITDA of ₹8,028 Mn. It highlights Strides' debut S&P Global Corporate Sustainability Assessment, where it received an ESG score of 76/100. The ESG section describes a double materiality exercise and developing climate, biodiversity and human-rights assessments. Environmental disclosures also report that 51.6% of total site power consumption came from renewable sources.
Services
From bulk PDFs to structured indicators and machine-readable documents.